Cost-effectiveness in hepatitis B [3] (multiple letters)

Annals of Internal Medicine

Volumn 143, Issue 10, 2005, Pages 757-759

  Weitzman, Gil ^a   Jacobson, Ira ^a   Spiegel, Brennan M R ^b   Martin, Paul ^b   Kanwal, Fasiha ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ENTECAVIR; INTERFERON; LAMIVUDINE; NUCLEOSIDE ANALOG; TELBIVUDINE;

CHRONIC HEPATITIS; COST EFFECTIVENESS ANALYSIS; CROSS RESISTANCE; DRUG POTENCY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; LIVER CIRRHOSIS; LIVER FIBROSIS; MONOTHERAPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMATIC REVIEW; VIRUS MUTATION; VIRUS RESISTANCE;

EID: 28044439848     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-143-10-200511150-00021     Document Type: Letter

References (0)